Breckenridge Pharmaceutical announces strategic collaboration with Medichem
Feb 05, 2026 BERKELEY HEIGHTS, N.J., Feb. 5, 2026 /PRNewswire/ — Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the U.S., announced a strategic collaboration with Medichem Solutions S.L., a subsidiary of Medichem, encompassing a basket of injectable products used across therapeutic areas such as anesthesia, critical care, and emergency […]
Breckenridge Pharmaceutical announces final FDA approval for Dehydrated Alcohol Injection, USP (generic for Ablysinol®)
Berkeley Heights, New Jersey, June 24, 2025 Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced today that the Food and Drug Administration (FDA) has granted approval of its Dehydrated Alcohol Injection, USP, 5 mL of ≥ 99% by volume ethyl alcohol Single-Dose […]
Breckenridge announces final FDA approval for Everolimus tablets for oral suspension, AB-rated to AFINITORDISPERZ ®
Berkeley Heights, New Jersey, January 29, 2025 Breckenridge Pharmaceutical, Inc.,-the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, – announced today that the Food and Drug Administration (FDA) has granted final approval of Everolimus Tablets for Oral Suspension (TFOS), 2mg, 3mg and 5mg, a generic version of […]
Breckenridge announces final FDA approval for Methadone Hydrochloride Multi-Dose Injection
Berkeley Heights, New Jersey, December 18, 2024 Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, announced today that the U.S. Food and Drug Administration has granted final approval of its Methadone Hydrochloride Injection USP, 200 mg/20 mL (10 mg/mL) Multi-Dose Vial which it […]
Cabazitaxel Approval announced
Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted approval of its Abbreviated New Drug Application for Cabazitaxel Intravenous Powder (generic for Jevtana Kit®). This product was developed in collaboration with Natco Pharma Limited.
Tentative Approval For Generic Pradaxa (Dabigatran)
Breckenridge Announces Tentative Approval of its ANDA for Dabigatran Etexilate Capsules (generic for Pradaxa®)
New-Product Agreement with PTS Pharma Signed
Breckenridge Signs New-Product Agreement with PTS Pharma
Miglustat (Zavesca) Approved
Breckenridge Announces Approval of its ANDA for Miglustat Capsules (generic for Zavesca®)
Penicillamine Capsule Launch
Breckenridge Pharmaceutical, Inc. Announces Launch of Penicillamine Capsules, USP (generic for Cuprimine®)
Lacosamide (Vimpat) Launch
Breckenridge Pharmaceutical, Inc. Announces Launch of Lacosamide Tablets, USP (generic version of Vimpat®) Manufactured by MSN Laboratories Private Limited
